Related Experiment Videos
A novel receptor involved in T-cell activation
B G Cocks1, C C Chang, J M Carballido
1DNAX Research Institute of Molecular and Cellular Biology, Human Immunology Department, Palo Alto, California 94304-1104, USA.
Nature
|July 20, 1995
Summary
Researchers discovered SLAM, a novel T-cell receptor, which enhances T-cell expansion and interferon-gamma production independently of the CD28 co-stimulatory pathway. This finding reveals new avenues for T-cell immune response modulation.
Area of Science:
- Immunology
- Molecular Biology
- Cellular Biology
Background:
- T-cell activation requires T-cell receptor and co-stimulatory signals.
- CD28 is a major co-stimulatory molecule, but not essential for all T-cell responses.
- The existence of alternative T-cell co-stimulatory pathways is suggested.
Purpose of the Study:
- To identify and characterize novel molecules involved in T-cell co-stimulation.
- To investigate the role of a newly identified glycoprotein, SLAM, in T-cell activation.
- To elucidate the signaling pathway of SLAM in T-cell responses.
Main Methods:
- Identification and characterization of a novel glycoprotein (SLAM).
- Analysis of SLAM expression on various T-cell populations.
- Investigating the effect of SLAM engagement on T-cell proliferation and cytokine production.
- Assessing the role of CD28 in SLAM-mediated T-cell activation.
Main Results:
- SLAM, a novel M(r) 70K glycoprotein, is identified and belongs to the immunoglobulin superfamily.
- SLAM is expressed on memory T cells, T-cell clones, thymocytes, and B cells, and induced on naive T cells upon activation.
- SLAM engagement enhances antigen-specific T-cell proliferation and interferon-gamma (IFN-gamma) production in a CD28-independent manner.
- SLAM induces a Th0/Th1 cytokine profile, upregulating IFN-gamma even in Th2 clones.
Conclusions:
- SLAM is a novel T-cell receptor involved in T-cell stimulation.
- SLAM engagement potentiates T-cell expansion and IFN-gamma production independently of CD28.
- SLAM represents a new pathway for modulating T-cell immune responses.